Nisa Investment Advisors, LLC Intellia Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,124 shares of NTLA stock, worth $16,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,124
Previous 1,068 5.24%
Holding current value
$16,623
Previous $23,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$19.72 - $27.36 $1,104 - $1,532
56 Added 5.24%
1,124 $23,000
Q2 2024

Jul 19, 2024
SELL
$20.02 - $27.22 $24,584 - $33,426
-1,228 Reduced 53.48%
1,068 $23,000
Q1 2024

May 01, 2024
SELL
$23.82 - $32.8 $1,524 - $2,099
-64 Reduced 2.71%
2,296 $63,000
Q4 2023

Jan 25, 2024
SELL
$23.16 - $32.34 $2,316 - $3,234
-100 Reduced 4.07%
2,360 $71,000
Q3 2023

Nov 02, 2023
SELL
$31.62 - $45.78 $1.9 Million - $2.75 Million
-59,990 Reduced 96.06%
2,460 $77,000
Q2 2023

Aug 11, 2023
BUY
$34.58 - $46.03 $2.09 Million - $2.78 Million
60,470 Added 3054.04%
62,450 $2.55 Million
Q1 2023

May 02, 2023
BUY
$33.3 - $44.82 $666 - $896
20 Added 1.02%
1,980 $74,000
Q4 2022

Feb 02, 2023
SELL
$33.21 - $62.69 $3,719 - $7,021
-112 Reduced 5.41%
1,960 $68,000
Q3 2022

Nov 07, 2022
BUY
$53.92 - $71.7 $29,763 - $39,578
552 Added 36.32%
2,072 $109,000
Q2 2022

Aug 03, 2022
SELL
$38.49 - $76.21 $13,471 - $26,673
-350 Reduced 18.72%
1,520 $79,000
Q1 2022

Apr 29, 2022
SELL
$58.27 - $118.99 $71,089 - $145,167
-1,220 Reduced 39.48%
1,870 $136,000
Q4 2021

Feb 03, 2022
SELL
$100.76 - $138.36 $2.36 Million - $3.24 Million
-23,401 Reduced 88.34%
3,090 $292,000
Q3 2021

Oct 18, 2021
BUY
$132.37 - $176.78 $3.1 Million - $4.14 Million
23,441 Added 768.56%
26,491 $3.55 Million
Q4 2020

Jan 25, 2021
BUY
$18.83 - $63.53 $17,888 - $60,353
950 Added 45.24%
3,050 $166,000
Q3 2020

Oct 20, 2020
BUY
$17.47 - $24.93 $36,687 - $52,353
2,100 New
2,100 $42,000
Q4 2018

Jan 17, 2019
SELL
$11.39 - $27.13 $194,769 - $463,923
-17,100 Closed
0 $0
Q3 2018

Oct 16, 2018
BUY
$25.78 - $32.6 $234,598 - $296,660
9,100 Added 113.75%
17,100 $489,000
Q3 2017

Oct 13, 2017
BUY
$15.16 - $25.75 $121,280 - $206,000
8,000
8,000 $199,000

Others Institutions Holding NTLA

# of Institutions
315
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.12B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email